 MINNEAPOLIS, Dec. 2, 2020 PRNewswire -- Bio-Techne Corporation NASDAQ: TECH and Regulus Therapeutics NASDAQ: RGLS announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease ADPKD... 